Traverse City Launches First National Long COVID Treatment Center

A groundbreaking healthcare initiative is set to launch this week in Traverse City, Michigan, marking a significant step in the treatment of long COVID. The first national healthcare center dedicated to this condition will combine the innovative approach of local firm HealthBio with the extensive reach of Celly Health, a national primary care provider. This partnership aims to enhance access to effective treatment plans for patients across the United States.

At the helm of this initiative is Dr. Bruce Patterson, who previously served as the director of clinical virology and co-director of the AIDS Research Center at Stanford University. His work at HealthBio has focused on repurposing existing medications to address the lingering effects of COVID-19. The treatment regimen proposed by Dr. Patterson spans six to twelve weeks and incorporates maraviroc, an FDA-approved drug used for HIV treatment, and atorvastatin, which is typically prescribed for high cholesterol management.

Expanding Access Through Telehealth

The new national center will be situated within the Celly Health Medical Group offices at the Bayview Professional Centre in Traverse City. While patients can access care on-site, the program is designed to accommodate telehealth services, facilitating even broader reach. Celly Health is actively exploring additional locations to ensure that the innovative treatment becomes widely available.

According to the Centers for Disease Control (CDC), long COVID is described as a chronic condition stemming from SARS-CoV-2 infection, persisting for a minimum of three months. This condition is currently estimated to impact approximately 20 million Americans, as reported by Yale Medicine. The innovative treatment approach developed by Dr. Patterson and HealthBio seeks to provide relief and recovery options for those affected.

The collaboration between HealthBio and Celly Health represents a pioneering effort in the healthcare landscape, as it integrates specialized long COVID care with comprehensive primary health services. This model not only aims to improve patient outcomes but also to streamline the treatment process, ensuring that individuals dealing with the aftermath of COVID-19 receive timely and effective care.

As the center opens its doors, it stands as a beacon of hope for many struggling with the debilitating effects of long COVID, highlighting the importance of innovation and collaboration in addressing public health challenges.